• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Garenoxacin mesylate hydrate

CAS No. 223652-90-2

Garenoxacin mesylate hydrate ( Garenoxacin mesylate [USAN]; BMS-284756-01; Garenoxacin mesylate )

产品货号. M13586 CAS No. 223652-90-2

A quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥381 有现货
5MG ¥527 有现货
10MG ¥672 有现货
25MG ¥1288 有现货
50MG ¥2163 有现货
100MG ¥3208 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Garenoxacin mesylate hydrate
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    A quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.
  • 产品描述
    A quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.Bacterial Infection Approved
  • 同义词
    Garenoxacin mesylate [USAN]; BMS-284756-01; Garenoxacin mesylate
  • 通路
    GPCR/G Protein
  • 靶点
    Antibacterial
  • 受体
    Antibacterial
  • 研究领域
    Infection
  • 适应症
    Bacterial Infection

化学信息

  • CAS Number
    223652-90-2
  • 分子量
    540.53
  • 分子式
    C24H26F2N2O8S
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: ≥ 30 mg/mL
  • SMILES
    C[C@@H]1c2ccc(cc2CN1)c3ccc4c(c3OC(F)F)n(cc(c4=O)C(=O)O)C5CC5.CS(=O)(=O)O.O
  • 化学全称
    3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-, methanesulfonate, hydrate (1:1:1)

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • Besifloxacin hydroch...

    A fourth-generation fluoroquinolone antibiotic that exhibits a broad spectrum in vitro activity against a wide range of Gram-positive and Gram-negative ocular pathogens.

  • 1835F03

    1835F03 is a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus.

  • PBP 10

    Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.